Deutsche Bank Sticks to Its Hold Rating for Stryker (SYK)

In a report issued on July 26, Pito Chickering from Deutsche Bank maintained a Hold rating on Stryker (SYKResearch Report), with a price target of $205.00. The company’s shares closed last Thursday at $219.03.

According to TipRanks.com, Chickering is a 2-star analyst with an average return of 0.9% and a 40.2% success rate. Chickering covers the Healthcare sector, focusing on stocks such as Aveanna Healthcare Holdings, Bausch + Lomb Corporation, and Zimmer Biomet Holdings.

Currently, the analyst consensus on Stryker is a Moderate Buy with an average price target of $239.31, implying a 13.0% upside from current levels. In a report issued on July 11, Bank of America Securities also downgraded the stock to Hold with a $215.00 price target.

See Insiders’ Hot Stocks on TipRanks >>

The company has a one-year high of $281.16 and a one-year low of $188.84. Currently, Stryker has an average volume of 1.48M.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Michigan-based Stryker Corp. was founded in 1941. The company provides medical technology products and services. It operates its business through the following segments: Orthopaedics, MedSurg and Neurotechnology and Spine.

Read More on SYK:

Tired of arriving late to the Big Returns Party?​
Most investors don’t have major gainers like TSLA or NVDA on their radar from the start.
The profusion of opinions on social media and financial blogs makes it impossible to distinguish between real growth potential and pure hype.
​​For the past decade, we have developed and perfected technology designed to help private investors, just like you, find the best opportunities, with the greatest upside potential, in any financial climate.​
Learn More